Evidence map›Paper›PMID 28950781›Full record

ArticleJournal of psychopharmacology (Oxford, England)2017

Blockade of dopamine D

Morgane Milienne-Petiot, Lucianne Groenink, Arpi Minassian, Jared W Young

Open access · greenAbstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Morgane Milienne-Petiot1 Department of Psychiatry, University of California San Diego, La Jolla, USA.
Lucianne Groenink2 Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Arpi Minassian1 Department of Psychiatry, University of California San Diego, La Jolla, USA.
Jared W Young1 Department of Psychiatry, University of California San Diego, La Jolla, USA.
University of California, San Diego · USUtrecht University · NLVA San Diego Healthcare System · US

Funding

Translational Methamphetamine AIDS Research Center (TMARC)P50DA026306 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2009 to 2018
$33.9M
Inhibitory Deficits in Mania and Hyperdopaminiergic MiceR01MH071916 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GEYER, MARK A, PERRY, WILLIAM · 2004 to 2014
$4.2M
Cannabis use and the endocannabinoid system in bipolar disorderR01DA043535 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PERRY, WILLIAM, YOUNG, JARED WILLIAM · 2018 to 2022
$3.3M
A model organism of brain circuitry and behavioral switching for bipolar disorderR01MH104344 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YOUNG, JARED WILLIAM · 2014 to 2017
$1.7M
Alpha 7 nicotinic receptor-mediated enhancement of reinforcement learningR21MH101579 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YOUNG, JARED WILLIAM · 2014 to 2015
$426k
NIDA NIH HHS P50 DA026306NIDA NIH HHS R01 DA043535NIMH NIH HHS R01 MH071916NIMH NIH HHS R01 MH104344NIMH NIH HHS R21 MH101579
6 · The paper itself

Abstract

backgroundPatients with bipolar disorder mania exhibit poor cognition, impulsivity, risk-taking, and goal-directed activity that negatively impact their quality of life. To date, existing treatments for bipolar disorder do not adequately remediate cognitive dysfunction. Reducing dopamine transporter expression recreates many bipolar disorder mania-relevant behaviors (i.e. hyperactivity and risk-taking). The current study investigated whether dopamine D

methodsDopamine transporter knockdown and wild-type littermate mice were tested in mouse versions of the Iowa Gambling Task (risk-taking), Progressive Ratio Breakpoint Test (effortful motivation), and Behavioral Pattern Monitor (activity). Prior to testing, the mice were treated with the dopamine D

resultsDopamine transporter knockdown mice exhibited hyperactivity and hyperexploration, hypermotivation, and risk-taking preference compared with wild-type littermates. SCH 23390 hydrochloride treatment decreased premature responding in dopamine transporter knockdown mice and attenuated their hypermotivation. SCH 23390 hydrochloride flattened the safe/risk preference, while reducing activity and exploratory levels of both genotypes similarly.

conclusionsDopamine transporter knockdown mice exhibited mania-relevant behavior compared to wild-type mice. Systemic dopamine D

Indexed as

AnimalsBehavior, AnimalBenzazepinesBipolar DisorderDopamineDopamine AntagonistsDopamine Plasma Membrane Transport ProteinsExploratory BehaviorGamblingMaleMiceMice, Inbred C57BLMotivationMotor ActivityQuality of LifeReceptors, Dopamine D1BenzazepinesDopamineDopamine AntagonistsDopamine Plasma Membrane Transport ProteinsReceptors, Dopamine D1SCH 23390Behavioral Pattern Monitorbipolar disorderbreakpointcognitionD1-family receptorsdopamine transporter knockdownIowa Gambling Tasklocomotor activitymaniarisk-taking

Identifiers

PMID28950781
PMCPMC10773978
OpenAlexW2760114247

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.